##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

Published Mar 10, 2014

Dong Wang  

Abstract

A powerful and complicated defense system exists within the cell and the whole body to protect against “irresponsible” cell growth and to deal harshly with most wannabe cancerous cells. However, occasionally the malfunction of one of these systems may result in an uncontrolled cell growth, which has been found taking the first step toward becoming carcinogenesis. Immune system is the most important defense system to protect the host from diseases. There is strong evidence showing that immune system also plays an essential role in providing significant protection against cancer. However, how the immune system works in defending and fighting against cancer and what is the exact molecular mechanisms of this process are still unknown. We herein review the historical change of the immune-associated cancer therapy and then provide evidence on the exploration of the relationship between the immune system and cancer disease. Moreover, an outline about the serendipity discovery of the Spontaneous Regression/Complete Resistant mice and the corresponding selective cancer killing mechanism of which is mediated entirely by leukocytes from the innate immunity is discussed. In addition, based on the outstanding curative effect on the animal model, a promising anti-tumor therapy method, Leukocyte Infusion Therapy, has been approved by FDA and is being preceded in conducting clinical trials.

##plugins.themes.bootstrap3.article.details##

Keywords

Cancer Immunotherapy, Immune Surveillance, Spontaneous Regression, Granulocyte, Cancer Killing Activity

References
1. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005; 294 (10): 1255-9.

2. Hajek E, Gutiérrez J, Espinosa d. Seasonality of mortality in human populations of Chile as related to a climatic gradient. Int J Biometeorol 1984; 28 (1): 29-38.

3. Davis RE, Knappenberger PC, Michaels PJ, Novicoff WM. Seasonality of climate-human mortality relationships in US cities and impacts of climate change. Clim Res 2004; 26 (1): 61-76.

4. Sompayrac L. How the immune system works, 4th Edition. Wiley-Blackwell (Ed.), ISBN: 978-0-470-65729-4, 2012; pp1-12.

5. Everson TC, Cole WH. Spontaneous regression of cancer: preliminary report. Ann Surg 1956; 144 (3): 366.

6. Everson TC. Spontaneous regression of cancer. Prog Clin Cancer 1966; 3: 79-95.

7. Wiernik, PH. Spontaneous regression of hematologic cancers. Natl Cancer Inst Monograph 1976; 44: 35-8.

8. Challis G, Stam H. The spontaneous regression of cancer: a review of cases from 1900 to 1987. Acta Oncologica 1990; 29 (5): 545-50.

9. Coley WB. The treatment of malignat tumors by repeated inoculations of erysipelas: with a report of ten original cases. Am J Med Sci 1893; 105 (5): 487-510.

10. Wiemann B, Starnes CO. Coley's toxins, tumor necrosis factor and cancer research: a historical perspective. Pharmacol Therap 1994; 64 (3): 529-64.

11. Ehrlich P. Ueber den jetzigen stand der Karzinomforschung. Ned. Tijdschr. Geneeskd 1909; 5: 273-90.

12. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002; 3(11): 991-8.

13. Southam CM, Moore AE, Rhoads CP. Homotransplantation of human cell lines. Science 1957: 125 (3239): 158-60.

14. Wang WY, Wang D. Granulocyte therapy for cancer. Sci Insights 2013; 2 (2): 43-4.

15. Cui Z, Willingham MC, Hicks AM, Alexander-Miller MA, Howard TD, Hawkins GA, Miller MS, Weir HM, Du W, DeLong CJ. Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice. Proc Natl Acad Sci U S A 2003; 100 (11): 6682-7.

16. Hicks AM, Riedlinger G, Willingham MC, Alexander-Miller MA, Von Kap-Herr C, Pettenati MJ, Sanders AM, Weir HM, Du W, Kim J. Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proc Natl Acad Sci U S A 2006; 103 (20): 7753-8.

17. Cui Z, Willingham MC. Human granulocytes kill cervical cancer cells (video). https://www.youtube.com/watch?v=nJEFcNbEWQs.

18. Riedlinger G, Adams J, Stehle JR, Blanks MJ, Sanders AM, Hicks AM, Willingham MC, Cui Z. The spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interaction. BMC Cancer 2010; 10 (1): 179.

19. Blanks MJ, Stehle JR, Du W, Adams JM, Willingham MC, Allen GO, Hu JJ, Lovato J, Molnar I, Cui Z. Novel innate cancer killing activity in humans. Cancer Cell Int 2011; 11 (26): 1-7.

20. The South Florida Bone Marrow/Stem Cell Transplant Institute, Clinical trial protocol (08001-BMSCTI), http://www.bmscti.org/clinicaltrials.htm.
How to Cite
Wang, D. (2014). Granulocyte Therapy for Cancer: A Prospective Review. Science Insights, 7(1), 139–143. https://doi.org/10.15354/si.14.re009
Section
Review